NEW YORK, July 23 - Large Scale Biology reported revenues of $0.9 million for the second quarter, compared to $490,000 in the same period last year.
The Vacaville, Calif., company had a net loss of $6.2 million for the quarter, compared to $9.6 million for the second quarter of 2002.
LSBC's R&D expenses narrowed to $2.8 million, from $5.9 million in the year-ago quarter. These expense reductions follow a restructuring program announced in June, in which the company plans to cut costs $5 million within the year.
At the end of the second quarter, the company had $15.0 million in cash and marketable securities.